[ad_1] Mankind Pharma has officially completed the amalgamation of three of its subsidiaries—Shree Jee Laboratory Private Limited, JPR Labs Private Limited, and Jaspack Industries Private Limited—into the company, effective March 29, 2025. The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench, which sanctioned the Scheme of Arrangement under the […]
Mankind Pharma receives ₹111.68 crore Income Tax demand, plans to appeal – CNBC TV18
[ad_1] Pharmaceutical firm Mankind Pharma Ltd on Friday (February 28) said it has received a ₹111.68 crore tax demand from the Income Tax Department for Assessment Year 2021-22. The order, issued by the Deputy Commissioner of Income Tax, Central Circle 29, New Delhi, on February 25, 2025, was received by the company on February 27, […]
Mankind Pharma Q3 Results | Revenue up 24%, net profit dips 16%, exports soar – CNBC TV18
[ad_1] Pharmaceutical firm Mankind Pharma Ltd on Thursday (January 23) reported a 16.2% year-on-year (YoY) drop in net profit at ₹380.2 crore for the third quarter that ended December 31, 2024, against ₹453.8 crore in the year-ago quarter. Company Value Change %Change The company’s revenue from operations increased 24% to ₹3,230 crore compared to ₹2,607 […]
Mankind Pharma pledges additional stake in Bharat Serums and Vaccines to secure NCDs – CNBC TV18
[ad_1] Mankind Pharma has pledged an additional 56.31% of its equity shares in Bharat Serums and Vaccines Ltd (BSV), its wholly owned subsidiary, to Catalyst Trusteeship Ltd as part of the terms for securing its listed non-convertible debentures (NCDs). Company Value Change %Change “…as per the terms and conditions of 3 Debenture Trust Deeds executed […]
Mankind Pharma’s board approves QIP of equity shares to raise ₹3,000 crore – CNBC TV18
[ad_1] Mankind Pharma Ltd has announced plans to raise nearly ₹3,000 crore by launching a qualified institutions placement (QIP) of equity shares. The pharmaceutical company’s Fund Raising Committee of Directors, in a meeting held on December 20, 2024, approved the allotment of 1.19 crore equity shares of the company at a face value of ₹1 […]
Mankind Pharma set to launch QIP to raise ₹3,000 crore: sources – CNBC TV18
[ad_1] Mankind Pharma is set to launch a Qualified Institutional Placement (QIP) to raise up to ₹3,000 crore, according to sources. The indicative issue price for the QIP is expected to be approximately ₹2,520 per share, which could lead to an equity dilution of 2.9% on a post-issue basis, sources added. Company Value Change %Change […]
Mankind Pharma to raise up to ₹10,000 crore through NCDs – CNBC TV18
[ad_1] Drug firm Mankind Pharma Ltd on Friday (September 20) said its board of directors has approved a significant fundraising initiative. The company plans to raise up to ₹10,000 crore through the issuance of non-convertible debentures (NCDs) and commercial papers (CPs) via private placement. To facilitate this process, the board has constituted a Fund Raising […]
Mankind Pharma to acquire Bharat Serums and Vaccines for ₹13,630 crore — CNBC-TV18 newsbreak confirmed – CNBC TV18
[ad_1] Pharmaceutical firm Mankind Pharma Ltd on Thursday (July 25) said it will acquire a 100% stake in Bharat Serums and Vaccines Ltd (BSV) from Advent International for an enterprise value of approximately ₹13,630 crore, subject to closing-related adjustments, confirming a CNBC-TV18 newsbreak. “The company has entered into a definitive agreement to acquire a 100% […]